As expected, BA-treated tumours had reduced expression of TGF-β target genes (Thbs1, Vegfa, Runx1), as well as genes linked to ascites production (Vegfa, see Supplementary Table 2 and Supplementary Fig. S2b). The gene discussed is RUNX1; the disease is neoplasm.